Compounds > actinium
Page last updated: 2024-08-22

actinium and 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid

actinium has been researched along with 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Bander, NH; Borchardt, P; Curcio, MJ; Frank, RK; Lai, LT; Ma, D; McDevitt, MR; Miederer, M; Pellegrini, V; Scheinberg, DA; Simon, J; Wu, K1
Holland, JP; Lewis, JS; May, C; McDevitt, MR; Ruggiero, A; Scheinberg, DA; Sprinkle, SR; Villa, CH1
Blechert, B; Bruchertseifer, F; Essler, M; Gärtner, FC; Morgenstern, A; Neff, F; Seidl, C; Senekowitsch-Schmidtke, R1
Bruchertseifer, F; Denkova, AG; Heskamp, S; Kip, A; Kruijff, RM; Molkenboer-Kuenen, J; Morgenstern, A; Raavé, R1
Chea, J; Colcher, D; Li, L; Liu, A; Miller, AD; Minnix, M; Poku, E; Rockne, RC; Shively, JE; Wong, JYC; Yazaki, PJ1

Other Studies

5 other study(ies) available for actinium and 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid

ArticleYear
Tumor therapy with targeted atomic nanogenerators.
    Science (New York, N.Y.), 2001, Nov-16, Volume: 294, Issue:5546

    Topics: Actinium; Alpha Particles; Animals; Antibodies, Monoclonal; Female; Half-Life; Heterocyclic Compounds, 1-Ring; Humans; Immunoconjugates; Linear Energy Transfer; Lymphoma; Male; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms; Prostate-Specific Antigen; Prostatic Neoplasms; Radioimmunotherapy; Survival Rate; Tumor Cells, Cultured

2001
Imaging and treating tumor vasculature with targeted radiolabeled carbon nanotubes.
    International journal of nanomedicine, 2010, Oct-05, Volume: 5

    Topics: Actinium; Adenocarcinoma; Animals; Cell Line, Tumor; Colonic Neoplasms; Deferoxamine; Heterocyclic Compounds, 1-Ring; Humans; Male; Mice; Mice, Nude; Nanomedicine; Nanotubes, Carbon; Neovascularization, Pathologic; Positron-Emission Tomography; Radioimmunodetection; Radioimmunotherapy; Radioisotopes; Radiopharmaceuticals; Xenograft Model Antitumor Assays; Zirconium

2010
Therapeutic efficacy and toxicity of 225Ac-labelled vs. 213Bi-labelled tumour-homing peptides in a preclinical mouse model of peritoneal carcinomatosis.
    European journal of nuclear medicine and molecular imaging, 2012, Volume: 39, Issue:4

    Topics: Actinium; Animals; Bismuth; Cell Line, Tumor; Disease Models, Animal; Heterocyclic Compounds, 1-Ring; Humans; Isotope Labeling; Kidney; Mice; Organometallic Compounds; Pentetic Acid; Peptides; Peritoneal Neoplasms; Radioisotopes; Treatment Outcome; Xenograft Model Antitumor Assays

2012
The in vivo fate of
    Scientific reports, 2019, 08-12, Volume: 9, Issue:1

    Topics: Actinium; Alpha Particles; Animals; Breast Neoplasms; Cell Line, Tumor; Chelating Agents; Drug Carriers; Female; Heterocyclic Compounds, 1-Ring; Humans; Injections, Intralesional; Injections, Subcutaneous; Mice; Mice, Inbred BALB C; Radiopharmaceuticals; Survival Analysis; Tumor Burden

2019
TAG-72-Targeted α-Radionuclide Therapy of Ovarian Cancer Using
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2021, Volume: 62, Issue:1

    Topics: Actinium; Alpha Particles; Animals; Antibodies, Monoclonal; Antigens, Neoplasm; Cell Line, Tumor; Cell Transformation, Neoplastic; Female; Heterocyclic Compounds, 1-Ring; Humans; Isotope Labeling; Mice; Molecular Targeted Therapy; Ovarian Neoplasms; Radioimmunotherapy; Tissue Distribution

2021